Telehealth Buprenorphine for pregnant and postpartum women with opioid use disorder
Official title: Availability of Telehealth-Delivered Buprenorphine Treatment for Pregnant and Postpartum Women with Opioid Use Disorder: A Mixed Methods Study
Funded at Rand Corporation · NIH-11366068 · Data updated 2026-11-12
A national study at RAND is testing how delivering buprenorphine treatment through telehealth affects pregnant and postpartum women with opioid use disorder.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | September 1, 2026 |
| Project end | June 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $872,634 |
| NIH project number | 1R01DA063704-01A1 |
| Project ID | NIH-11366068 on NIH RePORTER |
Who could benefit from this research
✓Could help
Pregnant or up to several weeks postpartum women with opioid use disorder who are or could be treated with buprenorphine and have access to telehealth.
✕Less likely to help
Women without OUD or those not seeking MOUD may not benefit from this telehealth approach.
What this research studies
This project explores whether delivering buprenorphine via telehealth can help pregnant and postpartum women access and stay on treatment for opioid use disorder. It uses a mixed-methods approach to understand barriers, experiences, and outcomes, aiming to improve health for both mother and baby. The research will examine access to care, appointment wait times, transportation and childcare challenges, and stigma, to identify how telehealth can reduce these obstacles. Results could inform policies and clinic practices to make MOUD more reachable during the perinatal period.
Why it matters
Potential benefit: If successful, the study could support broader use of telehealth buprenorphine to improve treatment access and outcomes for mothers and infants.
How similar studies have gone: Preliminary evidence suggests telehealth can improve access and retention, but perinatal-specific data remain limited and this study seeks to build on that.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Landis, Rachel Keller — Rand Corporation
- Study coordinator: Landis, Rachel Keller
Related research
Other NIH-funded projects on the same topics.
-
Digital tool to reduce self-stigma for pregnant/postpartum women with opioid use disorder
A digital program helps pregnant and new mothers with opioid use disorder feel better about themselves and stay connected to treatment.
-
A digital tool to help pregnant and postpartum women with opioid use disorder reduce self-stigma
This study is testing a helpful app called Enhearten for pregnant and new moms dealing with opioid use disorder, aiming to support them in overcoming feelings of shame and connect them with the care they need.
-
Helping new parents recover from opioid use disorder with mobile therapy
This study is creating a helpful mobile app for new moms recovering from opioid use disorder, offering support and tools to help them stay on track during a challenging time after giving birth.
-
Understanding how social connections affect recovery from opioid use disorder after childbirth
This study is looking at how having strong social connections can help new moms with opioid use disorder feel better and stay on track in their recovery during the months after giving birth, and it aims to find out the best ways to support them through this journey.
-
Personalized treatment for women with opioid use disorder after childbirth
This study is looking to create better treatment plans for women with opioid use disorder after they give birth, by personalizing care to fit their unique needs and helping them stay healthy and supported during this important time.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.